Form 8-K - Current report:
SEC Accession No. 0001213900-25-044174
Filing Date
2025-05-15
Accepted
2025-05-15 16:05:09
Documents
17
Period of Report
2025-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0241685-8k_aditxt.htm   iXBRL 8-K 41403
2 SECURITIES PURCHASE AGREEMENT DATED MAY 9, 2025 ea024168501ex10-1_aditxt.htm EX-10.1 183213
3 SENIOR SECURED NOTE DATED MAY 9, 2025 ea024168501ex10-2_aditxt.htm EX-10.2 75344
4 FORM OF FORBEARANCE AGREEMENT ea024168501ex10-3_aditxt.htm EX-10.3 53839
5 TRANSCRIPT OF WEEKLY UPDATE - MAY 9, 2025 ea024168501ex99-1_aditxt.htm EX-99.1 31939
  Complete submission text file 0001213900-25-044174.txt   660459

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adtx-20250509.xsd EX-101.SCH 3008
7 XBRL LABEL FILE adtx-20250509_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE adtx-20250509_pre.xml EX-101.PRE 22354
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0241685-8k_aditxt_htm.xml XML 3784
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 25952609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)